Streetbeat News

CAMP

CAMP4 Therapeutics Corporation

https://www.camp4tx.com/

Industry

Biotechnology

CAMP4 Therapeutics Corp. operates as a biotechnology company which engages in the discovery of treatment options for patients. The company was founded by Richard A. Young and Leonard Zon in 2015 and is headquartered in Cambridge, MA.

Open

9.96

Mkt cap

158M

Volume

41K

High

9.99

P/E Ratio

-3.18

52-wk high

12.30

Low

8.00

Div yield

N/A

52-wk low

7.80

U.S. stocks traded higher with the Dow Jones index gaining more than 300 points. Information technology shares rose by 1.8%. U.S. nonfarm payrolls rose by 336,000 in September, above market estimates. ParaZero Technologies, Vaccinex, and Applied UV saw significant stock increases. CalAmp Corp., OMNIQ Corp., and ShiftPixy saw significant stock decreases. Gold and oil prices increased.

Portfolio Pulse from Lisa Levin

October 06, 2023 | 6:31 pm

The article lists the stocks that gained and lost the most in Friday's mid-day session. Among the gainers were Applied UV, Inc., ParaZero Technologies Ltd., and American Oncology Network, Inc. The losers included OMNIQ Corp., VivoPower International PLC, and CalAmp Corp. The article also mentions several other stocks that experienced significant price changes.

Portfolio Pulse from Lisa Levin

October 06, 2023 | 5:59 pm

During Friday's intraday session, several information technology stocks experienced significant movements. Gainers included Tempo Automation Holdings (TMPO), Rubicon Technologies (RBT), Akoustis Technologies (AKTS), Cambium Networks (CMBM), Datasea (DTSS), and Rigetti Computing (RGTI). Losers included OMNIQ (OMQS), CalAmp (CAMP), ComSovereign Holding (COMSP), Aehr Test Systems (AEHR), Casa Systems (CASA), and Saverone 2014 (SVRE).

Portfolio Pulse from Benzinga Insights

October 06, 2023 | 5:31 pm

CalAmp's Q2 revenue fell short of expectations, leading to a downgrade of the stock to 'Hold' by Craig-Hallum. This has resulted in a decrease in the company's share price.

Portfolio Pulse from Bill Haddad

October 06, 2023 | 3:12 pm

Craig-Hallum analyst Anthony Stoss has downgraded CalAmp (NASDAQ:CAMP) from Buy to Hold and set a price target of $0.5.

Portfolio Pulse from Benzinga Newsdesk

October 06, 2023 | 1:58 pm

Roth MKM analyst Scott Searle maintains a 'Buy' rating on CalAmp (NASDAQ:CAMP) but has lowered the price target from $6 to $5.

Portfolio Pulse from Benzinga Newsdesk

October 06, 2023 | 1:13 pm

In Friday's pre-market session, several IT stocks showed significant movement. Aurora Mobile (JG), Maxeon Solar Technologies (MAXN), Marin Software (MRIN), Taoping (TAOP), and AEye (LIDR) saw gains, while OMNIQ (OMQS), Aehr Test Systems (AEHR), CalAmp (CAMP), SMX (Security Matters) (SMX), MicroAlgo (MLGO), and LG Display Co (LPL) experienced losses.

Portfolio Pulse from Benzinga Insights

October 06, 2023 | 1:06 pm

Levi Strauss & Co reported better-than-expected Q3 earnings but missed sales estimates and lowered its annual guidance, causing its shares to fall 1.2%. OMNIQ Corp. announced a proposed public offering of common stock, leading to a 37.5% drop in its shares. Aehr Test Systems reported positive Q1 earnings and sales results and reiterated its FY24 guidance, but its shares dipped 12.2%. CalAmp Corp. reported weaker-than-expected Q2 sales and a quarterly loss, causing its shares to fall 13.7%. Park Aerospace Corp. reported flat earnings and decreased sales for Q2 FY2024, leading to an 8.5% drop in its shares.

Portfolio Pulse from Lisa Levin

October 06, 2023 | 12:52 pm

During Thursday's after-market session, several information technology stocks saw significant movement. Gainers included Castellum (CTM), Iveda Solutions (IVDA), Lantronix (LTRX), WISeKey Intl Holding (WKEY), Inuvo (INUV), and Edgio (EGIO). Losers included OMNIQ (OMQS), CalAmp (CAMP), Aehr Test Systems (AEHR), SMX (Security Matters) (SMX), Quantum (QMCO), and WaveDancer (WAVD).

Portfolio Pulse from Benzinga Insights

October 05, 2023 | 9:31 pm

CalAmp reported Q2 losses of $(0.11) per share, missing the analyst consensus estimate of $0.03 by 466.67%. The company's quarterly sales were $61.70 million, missing the analyst consensus estimate of $70.35 million by 12.30%. This represents a 15.28% decrease over sales from the same period last year.

Portfolio Pulse from Happy Mohamed

October 05, 2023 | 8:32 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.